Skip to main content
Clinical Trials/NCT05815043
NCT05815043
Completed
Not Applicable

Effects of Sodium Intake on Arterial Stiffness in Black Adults

Texas State University1 site in 1 country34 target enrollmentDecember 13, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Texas State University
Enrollment
34
Locations
1
Primary Endpoint
Cardio-ankle vascular index
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to explore the influence of sodium intake on arterial stiffness in African American/Black adults.

Registry
clinicaltrials.gov
Start Date
December 13, 2022
End Date
December 30, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • African American or Black
  • Male or Female

Exclusion Criteria

  • pregnancy or within 60 days postpartum
  • having taken blood pressure (including diuretics beta-blockers, ACE inhibitors, angiotensin receptor blockers, and calcium channel blockers) or statin medications within the past 3 months
  • infection (viral or other) within the past 4 weeks
  • having adrenal or endocrine tumors (these could impact BP)
  • renal disease defined as a glomerular filtration rate (GFR) of less than 60
  • prior myocardial infarction
  • known coronary heart disease
  • personal history of stroke
  • heart failure
  • cardiac arrhythmias

Outcomes

Primary Outcomes

Cardio-ankle vascular index

Time Frame: This measurement will take approximately 1 minute and will be completed twice.

Cardio-ankle vascular index will be assessed using simultaneous arm and ankle blood pressures, EKG, and phonocardiography

Ambulatory blood pressure

Time Frame: This measurement will take approximately 24 hours and will be obtained from the date of enrollment until the date of completion of the study up to 10 days after enrollment.

24-hour ambulatory blood pressure monitoring will be completed on day 3 of each dietary condition.

Secondary Outcomes

  • Renal sodium excretion(This measurement will be obtained from the date of enrollment until the date of completion of the study up to 10 days after enrollment.)

Study Sites (1)

Loading locations...

Similar Trials